Corcept Therapeutics (CORT) Other Operating Expenses (2012 - 2026)
Corcept Therapeutics recorded quarterly Other Operating Expenses of $2.9 million in Q1 2026, up 13.28% quarter-over-quarter from $2.5 million in Q4 2025, and up 19.98% year-over-year from $2.4 million in Q1 2025.
Corcept Therapeutics' Other Operating Expenses history runs 15 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 19.98% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $13.5 million (up 25.18% YoY), while the FY2025 annual figure was $13.0 million, changed N/A from the prior year.
- Other Operating Expenses came in at $2.9 million for Q1 2026 at Corcept Therapeutics, up from $2.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $4.6 million in Q3 2025 to a low of $1.2 million in Q1 2022.
- A 5-year average of $2.3 million and a median of $2.4 million in 2025 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses surged 82.9% in 2024 and slipped 13.9% in 2025, its largest moves.
- Corcept Therapeutics' Other Operating Expenses stood at $1.5 million in 2022, then advanced by 26.82% to $1.9 million in 2023, then soared by 57.49% to $3.0 million in 2024, then retreated by 13.9% to $2.5 million in 2025, then climbed by 13.28% to $2.9 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.9 million, $2.5 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.88 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.27 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Sep 30, 2020 | 1.22 Mn |
| Jun 30, 2020 | 1.23 Mn |
| Mar 31, 2020 | 1.88 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Sep 30, 2019 | 1.45 Mn |
| Jun 30, 2019 | 1.38 Mn |
| Mar 31, 2019 | 1.24 Mn |
| Dec 31, 2018 | 1.58 Mn |
| Sep 30, 2018 | 1.31 Mn |
| Jun 30, 2018 | 1.15 Mn |
| Mar 31, 2018 | 1.17 Mn |
| Dec 31, 2017 | 1.16 Mn |
| Sep 30, 2017 | 976,000.00 |
| Jun 30, 2017 | 775,000.00 |
| Mar 31, 2017 | 646,000.00 |
| Dec 31, 2016 | 7.05 Mn |
| Sep 30, 2016 | 668,000.00 |
| Jun 30, 2016 | 426,000.00 |
| Mar 31, 2016 | 403,000.00 |
| Dec 31, 2015 | 364,000.00 |
| Sep 30, 2015 | 256,000.00 |
| Jun 30, 2015 | 439,000.00 |
| Mar 31, 2015 | 302,000.00 |
| Dec 31, 2014 | 258,000.00 |
| Sep 30, 2014 | 235,000.00 |
| Jun 30, 2014 | 215,000.00 |
| Mar 31, 2014 | 174,000.00 |
| Dec 31, 2013 | 61,000.00 |
| Sep 30, 2013 | 40,000.00 |
| Jun 30, 2013 | 23,000.00 |
| Mar 31, 2013 | 20,000.00 |
| Dec 31, 2012 | 19,000.00 |
| Sep 30, 2012 | 24,000.00 |
| Jun 30, 2012 | 48,000.00 |